Diagnosis and Treatment of Periodontal Disease in Patients With AML
Key facts
- Who runs it
- Masonic Cancer Center, University of Minnesota
- Trial code
- Status
- Withdrawn
- Started
- May 2022
- Expected to end
- Nov 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Scaling and Root Planing
- Record updated
- 22 February 2023
- Why it stopped
- PI left institution and research was cancelled due to his departure
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age >18 years
- Newly diagnosed or relapsed AML
- Planned intensive chemotherapy (Any regimen expected to require 3-4 weeks of inpatient stay)
- Antibacterial prophylaxis using levofloxacin 500 mg daily
- Sufficient time to perform periodontal examination and treatment by day 1 of chemotherapy
Who cannot take part
- Prior treatment for AML, except hydroxyurea or leukapheresis
- Documented infection at the time of enrollment
- Symptomatic periodontal disease
- ANC <0.5 x 10\^9/L at the time of enrollment
- Post-transfusion platelet count <50x10\^9/L at the time of enrollment
- Unstable for transfer to the School of Dentistry
- Fever at the time of enrollment
- SRP in the last 3 months
About the trial
What the trial wants to find out
This is a phase 2 randomized controlled trial of pre-chemotherapy periodontal deep cleaning in Acute Myelogenous Leukemia (AML) patients with asymptomatic periodontitis.
Read full original descriptionShow less
Once eligibility is confirmed, participants with periodontitis will be randomized in a 1:1 ratio to undergo treatment by scaling and root planing (SRP, "deep cleaning") (arm A) or receive no periodontal treatment (arm B). We will compare the incidence of Blood Stream Infection (BSI) during chemotherapy between the two arms.
Study participation will continue until day 28 of chemotherapy or discharge from hospital, whichever occurs first.
The 2 groups in the trial
- Arm A: Deep CleaningTreatment being tested
participants with periodontitis will undergo treatment by scaling and root planing (SRP)
Treatment: Scaling and Root Planing
- Arm B: No cleaningNo study treatment, for comparison
participants with periodontitis will undergo no periodontal treatment
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Early Diagnosis and Treatment of Periodontal Disease in Patients With AML to Reduce Bloodstream Infections During Chemotherapy
- Record updated
- 22 February 2023